What risk level is valproate for workers compensation claims?

valproate is classified as Low risk (2 risk points) by AllMeds. Anticonvulsant with moderate CNS depression effects and potential cognitive impairment.

Can you work or drive while taking valproate?

valproate is a CNS depressant that may cause sedation, drowsiness, and impaired coordination. It can affect driving ability and work capacity, particularly in safety-sensitive roles. Work capacity should be assessed on a case-by-case basis.

What should a case manager know about valproate?

Case managers should note that valproate is Low risk. It is a CNS depressant that may affect work capacity. Always check for drug interactions with other medications on the claim.

Anticonvulsant | Low Risk

valproate (Epilim)

Q: What schedule is valproate in Australia?

valproate is classified as S4 under the Therapeutic Goods Administration (TGA) in Australia.

What to know about valproate — also sold as Epilim, Valproate Winthrop EC 500, Sodium Valproate Sandoz, Epilim EC, Valpro EC 500 and 5 more: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.

valproate (brand names: Epilim, Valproate Winthrop EC 500, Sodium Valproate Sandoz, Epilim EC, Valpro EC 500 and 5 more) is classified as Low risk (2 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. Anticonvulsant with moderate CNS depression effects and potential cognitive impairment.

Key Takeaways

TGA Schedule: S4 in Australia
Risk level: Low (2 points)
CNS depressant: May cause sedation, impair driving, and affect work capacity
PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme

Scheduling and Classification

Jurisdiction	Classification	Status
Australia (TGA)	S4	PBS listed

Risk Profile

Risk Level Low

Risk Points 2

CNS Depressant Yes

Respiratory Risk No

Anticonvulsant with moderate CNS depression effects and potential cognitive impairment.

How valproate is regulated

valproate is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.

Work capacity impact: As a CNS depressant, valproate may impair driving, operating machinery, and cognitive function. Work capacity certificates should reflect any medication-related restrictions.

Australia TGA / PBS / State Schemes

Classified as S4 under the Therapeutic Goods Administration (TGA).

Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.

Check this medication against your full medication list

Run a full risk assessment including valproate interactions and compliance checks.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Try it free → Talk to Sales →

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.